Prolonged nitric oxide inhalation during from chronic hypoxia does not nitric oxide-dependent relaxation in pulmonary arteries

Chest

Volumn 126, Issue 6, 2004, Pages 1919-1925

  Maruyama, Junko ^a   Bao, Hua Jiang ^a   Maruyama, Kazuo ^a   Takata, Masao ^b   Miyasaka, Katsuyuki ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Acetylcholine; Hypoxia; Nitric oxide; Pulmonary hypertension; Recover; Right ventricular hypertrophy; Sodium nitroprusside; Vasodilation

Indexed keywords

8 BROMO CYCLIC GMP; ACETYLCHOLINE; CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG MECHANISM; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOBARISM; HYPOXIA; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 10444237254     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.6.1919     Document Type: Article

References (27)

1. Yoshida M, Taguchi O, Gabazza EC, et al. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:526-529
2. Yoshida M, Taguchi O, Gabazza EC, et al. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis. Eur Respir J 1997; 10:2051-2054
3. Bigatello LM, Hurford WE, Kacmarek RM, et al. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 1994; 80:761-770
4. Miller OI, Celermajer DS, Deanfield JE, et al. Very-low dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108:487-494
5. Kinsella JP, Neish SR, Shaffer E, et al. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820
6. Atz AM, Adatia I, Wesel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62:1759-1764
7. Perez-Penate G, Julia-Serda G, Pulido-Duque JM, et al. One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest 2001; 119:970-973
8. Snell GI, Salamonsen RF, Bergin P, et al. Inhaled NO used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995; 151:1263-1266
9. Channick RN, Newhart JW, Johnson FW, et al. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest 1996; 109:1545-1549
10. Yung GL, Kriett JM, Jamieson SW, et al. Outpatient inhaled NO in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation. J Heart Lung Transplant 2001; 20:1224-1227
11. Assreuy J, Cunha FQ, Liew FY, et al. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993; 108:833-837
12. Buga GM, Griscavage JM, Rogers NE, et al. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73:808-812
13. Dinh-Xuan AT, Higenbottam TW, Clelland CA, et al. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324:1539-1547
14. Maruyama J, Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries in rats. Am J Physiol 1994; 266:H2476-H2488
15. Maruyama J, Yokochi A, Maruyama K, et al. Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats. J Appl Physiol 1999; 86:1687-1695
16. Adnot S, Raffestin B, Eddahibi S, et al. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991; 87:155-162
17. Rabinovitch M, Gamble WJ, Miettinen OS, et al. Age and sex influence on pulmonary hypertension of chronic hypoxia and recovery. Am J Physiol 1981; 240:H62-H72
18. Jiang BH, Maruyama J, Yokochi A, et al. Prolonged NO inhalation fails to regress hypoxic vascular remodeling in rat lung. Chest 2004; 125:2247-2252
19. Roos CM, Frank DU, Xue C, et al. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. J Appl Physiol 1996; 80:252-260
20. Maruyama J, Maruyama K, Mitani Y, et al. Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol 1997; 272:H517-H524
21. Oka M, Ohnishi M, Takahashi H, et al. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am J Physiol 1996; 271:L419-L424
22. Roos CM, Rich GF, Uncles DR, et al. Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs. J Appl Physiol 1994; 77:51-57
23. Petros AJ. Down-regulation of endogenous nitric oxide production after prolonged administration [letter]. Lancet 1994; 344:191
24. Wedgwood S, McMullan DM, Bekker JM, et al. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 2001; 89:357-364
25. Dinerman JL, Lawson DL, Mehta JL. Interaction between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol 1991; 260:H698-H701
26. Nakagawa H, Okumura K, Hashimoto H, et al. Effects of atrial natriuretic poiypeptide and organic nitrates on levels of relaxation and cyclic nucleotide of canine coronary artery with and without endothelial injury. Heart Vessels 1988; 4:19-25
27. Maclean MR, Johnson ED, McCulloch KM, et al. Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 1997; 283:619-624